During the past decade, Holy Family Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Family Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Human Genome Sciences Inc." with 3 trials sponsored, "Erika Carmel ltd" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Can-Fite BioPharma" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Family Hospital" #1 collaborator was "Holy Family Hospital, Nazareth, Israel" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Beilinson Hospital, Petach Tikva,Israel" with 1 trials as a collaborator, "Hadassah Medical Organization" with 1 trials as a collaborator and "Hillel Yaffe Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Holy Family Hospital" are "NASH - Nonalcoholic Steatohepatitis" (3 trials), "Chronic Hepatitis C" (2 trials), "Crohn Disease" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "Holy Family Hospital" in a lesser frequency.

Most popular intervention types in "Holy Family Hospital" are "Drug" (15 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (4 trials), "Ribavirin" (3 trials), "albumin interferon alfa-2b" (2 trials) and "peginterferon alfa-2a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Holy Family Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Holy Family Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Holy Family Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Family Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".